Impact of COVID-19 lockdown on lifestyle adherence in stay-at-home patients with chronic coronary syndromes: Towards a time bomb.
Aged
COVID-19
/ epidemiology
Cardiovascular Diseases
/ epidemiology
Chronic Disease
Cross-Sectional Studies
Exercise
Female
France
/ epidemiology
Health Behavior
Humans
Life Style
Male
Medication Adherence
/ statistics & numerical data
Quarantine
/ legislation & jurisprudence
Rural Population
Smoking
/ epidemiology
Urban Population
Weight Gain
Adherence
COVID-19
Chronic coronary syndromes
Lifestyle
Lockdown
Journal
International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291
Informations de publication
Date de publication:
15 01 2021
15 01 2021
Historique:
received:
24
04
2020
revised:
06
07
2020
accepted:
26
08
2020
pubmed:
6
9
2020
medline:
30
12
2020
entrez:
5
9
2020
Statut:
ppublish
Résumé
We aimed to evaluate the impact of coronavirus disease 2019 (COVID-19)-related lockdown on adherence to lifestyle and drug regimens in stay-at-home chronic coronary syndromes patients living in urban and rural areas. A cross-sectional population-based study was perfomed in patients with chronic coronary syndromes. A sample of 205 patients was randomly drawn from the RICO (Observatoire des infarctus de Côte d'Or) cohort. Eight trained interviewers collected data by phone interview during week 16 (April 13 to April 19), i.e. 4 weeks after implementation of the French lockdown (start March 17, 2020). Among the 195 patients interviewed (of the 205, 3 had died, 1 declined, 6 lost), mean age was 65.5 ± 11.1 years. Only six patients (3%) reported drug discontinuation, mainly driven by media influence or family members. All 166 (85%) patients taking aspirin continued their prescribed daily intake. Lifestyle rules were less respected since almost half (45%) declared >25% reduction in physical activity, 26% of smokers increased their tobacco consumption by >25%, and 24% of patients increased their body weight > 2 kg. The decrease in physical activity and the increase in smoking were significantly greater in urban patients (P < .05). The COVID-19-related lockdown had a negative impact on lifestyle in a representative sample of stay-at-home CCS patients.
Sections du résumé
BACKGROUND
We aimed to evaluate the impact of coronavirus disease 2019 (COVID-19)-related lockdown on adherence to lifestyle and drug regimens in stay-at-home chronic coronary syndromes patients living in urban and rural areas.
METHODS
A cross-sectional population-based study was perfomed in patients with chronic coronary syndromes. A sample of 205 patients was randomly drawn from the RICO (Observatoire des infarctus de Côte d'Or) cohort. Eight trained interviewers collected data by phone interview during week 16 (April 13 to April 19), i.e. 4 weeks after implementation of the French lockdown (start March 17, 2020).
RESULTS
Among the 195 patients interviewed (of the 205, 3 had died, 1 declined, 6 lost), mean age was 65.5 ± 11.1 years. Only six patients (3%) reported drug discontinuation, mainly driven by media influence or family members. All 166 (85%) patients taking aspirin continued their prescribed daily intake. Lifestyle rules were less respected since almost half (45%) declared >25% reduction in physical activity, 26% of smokers increased their tobacco consumption by >25%, and 24% of patients increased their body weight > 2 kg. The decrease in physical activity and the increase in smoking were significantly greater in urban patients (P < .05).
CONCLUSIONS
The COVID-19-related lockdown had a negative impact on lifestyle in a representative sample of stay-at-home CCS patients.
Identifiants
pubmed: 32889019
pii: S0167-5273(20)33721-9
doi: 10.1016/j.ijcard.2020.08.094
pmc: PMC7462445
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
285-287Informations de copyright
Copyright © 2020. Published by Elsevier B.V.
Références
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
JAMA Cardiol. 2020 Jul 1;5(7):745-747
pubmed: 32242890
Anaesthesia. 2020 Jul;75(7):935-944
pubmed: 32259288
Eur J Prev Cardiol. 2020 Jun;27(9):906-908
pubmed: 32270698
JAMA Netw Open. 2020 Apr 1;3(4):e203032
pubmed: 32301989